Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Advantages of Ambulatory Blood Pressure Monitoring in Assessing the Efficacy of Antihypertensive Therapy

Advantages of Ambulatory Blood Pressure Monitoring in Assessing the Efficacy of Antihypertensive... The cumulative evidence in the past three decades situates ambulatory blood pressure monitoring (ABPM) as a central element in diagnosing and predicting the prognosis of subjects with hypertension. However, for various reasons, this diagnostic and prognostic importance has not been translated in equal measure into making decisions or guiding antihypertensive treatment. Mean 24-h, daytime, and night-time blood pressure estimates, the occurrence of divergent phenotypes between clinic measurements, and ABPM, as well as the main elements that determine blood pressure variability over 24 h, especially night-time dipping, are all elements that in addition to providing evidence for patient prognosis, can be used to guide antihypertensive treatment follow-up enabling greater precision in defining the effect of the drugs. In recent years, specific indices have been developed using 24-h monitoring, evaluate the duration of treatment action, the homogeneity of the effect over the monitoring period, and its possible effects on variability. In future controlled clinical trials on antihypertensive therapies it is necessary to evaluate the effects of those treatments on hard endpoints based on therapy guided by ABPM. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Advantages of Ambulatory Blood Pressure Monitoring in Assessing the Efficacy of Antihypertensive Therapy

Sierra, Alejandro
Cardiology and Therapy , Volume 4 (1) – Jun 16, 2015
Download PDF
13 pages

Loading next page...
 
/lp/springer-journals/advantages-of-ambulatory-blood-pressure-monitoring-in-assessing-the-B0D0JqZ6Ta
Publisher
Springer Journals
Copyright
Copyright © 2015 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-015-0043-1
pmid
26077732
Publisher site
See Article on Publisher Site

Abstract

The cumulative evidence in the past three decades situates ambulatory blood pressure monitoring (ABPM) as a central element in diagnosing and predicting the prognosis of subjects with hypertension. However, for various reasons, this diagnostic and prognostic importance has not been translated in equal measure into making decisions or guiding antihypertensive treatment. Mean 24-h, daytime, and night-time blood pressure estimates, the occurrence of divergent phenotypes between clinic measurements, and ABPM, as well as the main elements that determine blood pressure variability over 24 h, especially night-time dipping, are all elements that in addition to providing evidence for patient prognosis, can be used to guide antihypertensive treatment follow-up enabling greater precision in defining the effect of the drugs. In recent years, specific indices have been developed using 24-h monitoring, evaluate the duration of treatment action, the homogeneity of the effect over the monitoring period, and its possible effects on variability. In future controlled clinical trials on antihypertensive therapies it is necessary to evaluate the effects of those treatments on hard endpoints based on therapy guided by ABPM.

Journal

Cardiology and Therapy – Springer Journals

Published: Jun 16, 2015

References

  • Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama Study
    Kikuya, M; Ohkubo, T; Asayama, K
  • Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study
    Dolan, E; Stanton, A; Thijs, L
  • Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population. Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study
    Sega, R; Facchetti, R; Bombelli, M
  • Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM Registry
    Sierra, A; Banegas, JR; Segura, J; Gorostidi, M; Ruilope, LM
  • European Society of Hypertension position paper on ambulatory blood pressure monitoring
    O’Brien, E; Parati, G; Stergiou, G
  • European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
    Parati, G; Stergiou, G; O’Brien, E
  • Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring
    Schmieder, RE; Ruilope, LM; Ott, C; Mahfoud, F; Bohm, M
  • Clinical characteristics of isolated clinic hypertension
    Vinyoles, E; Felip, A; Pujol, E
  • Isolated clinic hypertension: diagnostic criteria based on 24-h blood pressure definition
    Vinyoles, E; Rodríguez-Blanco, T; Sierra, A
  • Effectiveness of blood pressure control outside the medical setting
    Banegas, JR; Segura, J; Sobrino, J
  • Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial
    Staessen, JA; Byttebier, G; Buntinx, F; Celis, H; O’Brien, ET; Fagard, R
  • Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis
    Mancia, G; Parati, G
  • Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis
    Ishikawa, J; Carroll, DJ; Kuruvilla, S; Schwartz, JE; Pickering, TG
  • Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with Hypertension
    Roush, GC; Fagard, RH; Salles, GF
  • Siesta and ambulatory blood pressure monitoring. Comparability of the afternoon nap and night sleep
    Bursztyn, M; Mekler, J; Wachtel, N; Ben-Ishay, D
  • Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation
    Verdecchia, P; Angeli, F; Borgioni, C; Gattobigio, R; Reboldi, G
  • Masked hypertension: a systematic review
    Bobrie, G; Clerson, P; Menard, J; Postel-Vinay, N; Chatellier, G; Plouin, PF
  • Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study
    Ohkubo, T; Kikuya, M; Metoki, H
  • Short- and long-term incidence of stroke in white-coat hypertension
    Verdecchia, P; Reboldi, GP; Angeli, F
  • Definition of white coat hypertension: ambulatory blood pressure, self-measured blood pressure or both?
    Sierra, A
  • Long-term risk of sustained hypertension in white-coat or masked hypertension
    Mancia, G; Bombelli, M; Facchetti, R
  • High prevalence of masked uncontrolled hypertension (MUCH) in people with treated hypertension
    Banegas, JR; Ruilope, LM; Sierra, A
  • Clinical features of 8,295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring
    Sierra, A; Segura, J; Banegas, JR
  • Prevalence of white-coat and masked hypertension in national and international registries
    Gorostidi, M; Vinyoles, E; Banegas, JR; Sierra, A
  • Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension
    Muxfeldt, ES; Fiszman, R; Souza, F; Viegas, B; Oliveira, FC; Salles, GF
  • 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    Mancia, G; Fagard, R; Narkiewicz, K
  • Dippers and non-dippers. [Letter]
    O’Brien, E; Sheridan, J; O’Malley, K
  • Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study
    Ohkubo, T; Hozawa, A; Yamaguchi, J
  • Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients
    Sierra, A; Redón, J; Banegas, JR
  • Diurnal blood pressure variation, risk categories, and antihypertensive treatment
    Sierra, A; Segura, J; Gorostidi, M; Banegas, JR; Cruz, JJ; Ruilope, LM
  • Nocturnal hypertension or non-dipping: which is better associated with the cardiovascular risk profile?
    Sierra, A; Gorostidi, M; Banegas, JR; Segura, J; Cruz, JJ; Ruilope, LM
  • Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study
    Kario, K; Pickering, TG; Umeda, Y
  • Morning surge in blood pressure and cardiovascular risk: evidence and perspectives
    Kario, K
  • Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study
    Kario, K; Saito, I; Kushiro, T
  • Assessment and management of blood-pressure variability
    Parati, G; Ochoa, JE; Lombardi, C; Bilo, G
  • Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
    Rothwell, PM; Howard, SC; Dolan, E
  • Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk
    Hermida, RC; Ayala, DE; Mojón, A; Fernández, JR
  • Calculation of trough-to-peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects
    Omboni, S; Parati, G; Zanchetti, A; Mancia, G
  • The smoothness index: a new reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction by treatment for hypertension
    Parati, G; Omboni, S; Rizzoni, D; Agabiti-Rosei, E; Mancia, G
  • The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment
    Rizzoni, D; Muiesan, ML; Salvetti, M
  • Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database
    Parati, G; Dolan, E; Ley, L; Schumacher, H
  • Resistant hypertension: diagnosis, evaluation and treatment: a scientific statement from the American Heart Association Professional Education Committee of The Council for High Blood Pressure Research
    Calhoun, DA; Jones, D; Textor, S
  • Clinical differences between resistant hypertensives and patients treated and controlled with three or les drugs
    Sierra, A; Banegas, JR; Oliveras, A
  • Incidence and prognosis of resistant hypertension in hypertensive patients
    Daugherty, SL; Powers, JD; Magid, DJ
  • New developments in the diagnosis and management of resistant hypertension
    Oliveras, A; Sierra, A
  • A controlled trial of renal denervation for resistant hypertension
    Bhatt, DL; Kandzari, DE; O’Neill, WW
  • Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force
    Piper, MA; Evans, CV; Burda, BU; Margolis, KL; O’Connor, E; Whitlock, EP